asthma symptoms , 3d render style, high resolution, photorealistic

Understanding Long Covid Asthma Symptoms

Long Covid can cause asthma symptoms that last even after recovering from the virus. It’s important to understand these symptoms to manage the condition effectively.

In this article, we will explore how Long Covid impacts asthma and discuss effective coping strategies. Understanding these lingering effects can help individuals make informed decisions about their treatment.

Let’s delve into the complexities of Long Covid asthma symptoms.

Understanding Long Covid Asthma Symptoms

Can you develop asthma after COVID-19?

Patients who have had COVID-19 may develop asthma. Symptoms like coughing, wheezing, and trouble breathing can arise after recovering from COVID-19. Some studies link COVID-19 to a higher asthma risk, especially in those with specific asthma types. Respiratory issues post-COVID-19, like breathlessness and chest pain, may hint at lung problems. This could trigger new asthma or worsen existing cases.

It’s vital to watch for lung function changes and inflammation to catch possible asthma after COVID-19. Regular monitoring can help handle lasting lung troubles effectively.

Is wheezing common after COVID?

Individuals who have recovered from COVID-19 might experience wheezing as a common symptom afterward. Some studies have found that a portion of patients could develop new-onset asthma following recovery from COVID-19. Symptoms like coughing, shortness of breath, and wheezing are commonly reported in these cases.

These individuals often respond well to asthma treatments like inhaled corticosteroids. This type of treatment can assist in symptom management and enhance asthma control.

In some cases, the development of asthma after a COVID-19 infection may be linked to eosinophilic inflammation in the airways. This inflammation can result in airflow obstruction and respiratory symptoms.

It is crucial to monitor respiratory symptoms, particularly wheezing, post-COVID-19 infection to ensure timely diagnosis and effective management of new-onset asthma. This is especially important for individuals with a history of lower respiratory infections or adult-onset asthma.

Understanding the connection between COVID-19 and asthma is essential for healthcare providers to deliver appropriate care to patients facing persistent respiratory symptoms following COVID-19 recovery.

Can COVID-19 make asthma worse?

COVID-19 can make asthma symptoms worse. Some people with asthma may have more severe symptoms or get asthma for the first time after having COVID-19.

Symptoms can include coughing, wheezing, chest pain, trouble breathing, and airflow blockage. In serious cases, patients might need to go to the hospital or ICU because of breathing problems like pneumonia.

COVID-19 can have long-term effects on asthma control and management. This can make it hard to breathe, cause shortness of breath, and affect quality of life.

To stay safe, people with asthma should keep taking their prescribed medications like inhaled corticosteroids (ICS) or long-acting muscarinic antagonists (LAMA). They should also stay in touch with healthcare providers regularly.

It’s important for patients to watch their symptoms closely, get medical help right away if they notice any breathing issues, and learn about vaccination options to lower the chance of getting asthma or making their current condition worse.

Can the COVID-19 vaccine cause you to develop asthma?

Some people with asthma may have asthma symptoms or asthma attacks after getting the COVID-19 vaccine. These cases are rare. For most patients, the benefits of getting vaccinated are greater than the risks.

Research is ongoing to understand why this happens. Some studies suggest that certain individuals may be more likely to have respiratory issues, like asthma, after vaccination.

It’s important for healthcare providers to watch closely for any signs of breathing problems after vaccination. These signs include coughing, wheezing, shortness of breath, or chest pain.

Knowing the risks of COVID-19 and vaccination for people with asthma is vital for managing their health. By staying informed and getting help if symptoms get worse after vaccination, individuals can handle asthma issues effectively.

Known risk factors for asthma

Known risk factors for asthma include:

  • Exposure to environmental triggers like air pollution, tobacco smoke, dust mites, and pet dander.
  • These factors can worsen respiratory symptoms such as coughing, wheezing, and chest pain in people with asthma.
  • A family history of asthma can increase the chance of developing asthma.
  • Genetics can make individuals more likely to get asthma.
  • Allergies, especially those related to immunoglobulin E (IgE), are also considered risk factors.
  • Allergies can cause coughing, shortness of breath, and airflow blockage in asthma patients.

Understanding these factors is important for managing asthma, watching symptoms, and lowering the risk of hospitalization or ICU visits. This holds true, especially in cases of post-COVID syndrome and long COVID-19. Healthcare providers can help improve asthma control and the overall quality of life for patients by recognizing and dealing with these risk factors.


Long Covid Asthma Symptoms:

  • Discussion highlights potential link between COVID-19 and new-onset asthma.
  • Patients with prior COVID-19 may develop coughing, wheezing, and shortness of breath.
  • Eosinophilic inflammation and T2-high nonallergic asthma phenotypes may play a role.


  • Monitor symptoms closely post-COVID.
  • Seek medical attention for coughing, shortness of breath, or chest pain.
  • Use inhaled corticosteroids and bronchodilators for symptom control.
  • Regular healthcare visits are essential for asthma management.
  • Stay informed on vaccination benefits to reduce COVID-19 impact on asthma.

How we reviewed this article:

The team reviewed the article’s criteria for credibility and accuracy. They checked the sources for reliability and currency. This helped to strengthen the article’s content.

Expert consultation was important for validating information. This was especially true for the rare link between COVID-19 and new-onset asthma.

The study looked at how COVID-19 affects asthmatic patients six to twelve months after infection. Factors like T2 asthma, pneumonia, and treatment effectiveness in reducing hospitalization risk were analyzed.

These findings highlighted the complex relationship between COVID-19 and asthma. It stressed the importance of closely monitoring and caring for patients with respiratory symptoms like coughing, wheezing, and difficulty breathing.

The study also examined COVID-19’s immediate and long-term effects on asthma. It underlined the importance of staying alert to potential developments like new-onset asthma in individuals with or recovering from COVID-19.

Read this next

Common symptoms of Long Covid related to asthma that readers should be aware of are:

  • Coughing
  • Wheezing
  • Dyspnea
  • Chest pain
  • Airflow obstruction

Individuals with asthma can determine if their symptoms are being exacerbated by COVID-19 through monitoring for:

  • Shortness of breath
  • Cough
  • Respiratory symptoms post-COVID infection

Factors such as prior COVID-19 infection, immune system response, and potential development of new-onset asthma should be considered. Risks associated with asthma after COVID-19 include hospitalization, ICU visits, and pneumonia.

Studies have shown that T2 asthma patients may have lower hospitalization rates and improved outcomes with specific treatments. Monitoring pulmonary function, mucus production, and airflow obstruction can aid in recognizing post-COVID syndrome impact on respiratory health.

Understanding baseline characteristics, odds ratios, and clinical features can assist in managing asthma based on acute phase COVID-19 outcomes longitudinally over 6-12 months.

Clinical Implications

Developing asthma after COVID-19 can have important clinical implications.

Patients who develop asthma post-COVID may have symptoms like coughing, wheezing, and shortness of breath.

It’s important for healthcare providers to assess these symptoms carefully by conducting respiratory evaluations, including pulmonary function tests and monitoring inflammation levels.

Treatment strategies may include inhaled corticosteroids, bronchodilators, and long-acting muscarinic antagonists to manage asthma symptoms that worsened after COVID-19.

Monitoring asthma control using tools like the asthma control test is essential in optimizing treatment outcomes for these patients, taking into account factors such as prior COVID-19 infection, age, and baseline characteristics.

Table I

Table I shows important details about patients with asthma who had COVID-19 before. It includes their age, gender, type of asthma, COVID-19 pneumonia, smoking status, and treatments.

These details help find connections between COVID-19 and asthma outcomes, like hospitalization rates and response to medicines.

The data in Table I is crucial in understanding long-term asthma symptoms after COVID-19. It highlights how people’s characteristics and health factors can affect the severity of the disease. For example, the link between COVID-19 pneumonia and male patients, smokers, and specific treatments gives clues about risks for worse outcomes in asthma patients after COVID-19. Knowing the prevalence of T2 asthma and how it affects hospitalization rates helps us understand how asthma type can impact the disease’s progress and treatment plans for up to a year after the infection.

This analysis helps create personalized treatment and monitoring plans for people who develop new asthma or have worsening symptoms after having COVID-19.

Table II

Table II provides insights into long Covid asthma symptoms after recent COVID-19 infection. This includes respiratory symptoms like coughing, wheezing, and shortness of breath. These symptoms show airflow blockage and airway inflammation common in asthma.

The table also shows the age range of patients with new asthma post-COVID-19. This helps us understand age as a potential risk factor for adult-onset asthma after the virus.

Additionally, Table II presents clinical details of patients with post-COVID-19 asthma. It covers symptom severity, hospitalization rates, and factors like pneumonia and smoking. Comparing these factors in patients with and without new asthma reveals insights into disease progression and outcomes for those with asthma symptoms post-COVID-19.

Study population

The study looked at asthmatic patients who had COVID-19 six to twelve months earlier.

The average age of the patients was 55, with 67% being women.

About 60.7% had T2 asthma, a specific asthma type.

The focus was on those with asthma who had symptoms worsen after COVID-19, showing how the virus affected asthma.

Patients were chosen based on having had COVID-19 and developing respiratory issues or new asthma.

Data collected included age, gender, and asthma history to study COVID-19’s effects on asthma patients.

Inclusion criteria: adults with prior COVID-19 and asthma.

Exclusion criteria may have included those without asthma or those who didn’t develop new asthma after COVID-19.

These criteria helped focus the study on COVID-19’s impact on asthma outcomes.

Data collection

The study analyzed data from asthmatic patients. They were admitted during the first and second COVID-19 waves. The data included demographic, clinical, and laboratory factors. These factors examined asthma history, COVID-19 infection details, and post-COVID-19 symptoms.

Methods used included assessing respiratory symptoms. These symptoms included coughing, wheezing, dyspnea, and chest pain. The aim was to evaluate the impact of prior COVID-19 infection on new-onset asthma.

Data collection techniques are crucial. They help in accurately identifying asthma symptoms post-COVID-19. This is important for distinguishing between asthma exacerbation and long Covid symptoms.

Factors examined in the study were age, gender, smoking status, T2 asthma phenotype, and prior COVID-19 infection. These factors were studied to understand the relationship between COVID-19 and asthma development.

The study emphasized the importance of meticulous data collection. It helps in assessing asthma after COVID-19. It also highlights the impact on patients’ respiratory health in the long term.

Statistical analyses

The study on Long Covid Asthma Symptoms used various methods for statistical analyses. This included calculating odds ratios and comparing demographic data.

The results revealed significant associations between COVID-19 pneumonia and patient characteristics like gender or smoking status. These factors influenced asthma outcomes.

Statistical tests validated these relationships, emphasizing the importance of considering asthma in individuals with previous COVID-19 infections.

Analyzing asthma symptoms after COVID-19 infection helped researchers identify risks such as airflow obstruction and higher hospitalization rates.

Understanding these statistical findings highlights the complex link between COVID-19 and asthma. This information guides potential interventions and care strategies for patients developing new-onset asthma or experiencing worsened symptoms post COVID-19 recovery.

The analysis offers valuable insights into the statistical significance of respiratory symptoms following COVID-19 and their impact on long-term asthma management.


Table 1

Table 1 in the study shows symptoms in patients with long COVID-19 and new-onset asthma.

It includes information on coughing, wheezing, chest pain, and more, highlighting their respiratory challenges.

The table also covers treatments like inhaled corticosteroids, IgE levels, nitric oxide measurements, and asthma control test scores.

Researchers use this data to analyze the link between COVID-19 and asthma development post-recovery.

Understanding how COVID-19 affects the respiratory system helps in managing long-term asthma symptoms.

The table helps in assessing hospitalization rates, ICU admissions, and lung function tests, contributing to asthma research post-COVID-19.

It identifies a connection between COVID-19 pneumonia, male patients, smokers, and specific treatments with asthma development.

The data offers insights into risk factors and clinical features influencing asthma progression after COVID-19.

It suggests that the immune response to COVID-19, airway inflammation, and asthma symptoms may be linked.

Table 2

Table 2 in the blog post shares data about Long Covid Asthma Symptoms. It focuses on respiratory issues in people with new-onset asthma after having COVID-19. The symptoms include coughing, wheezing, shortness of breath, and chest pain. The table shows how common these symptoms are and how they affect asthma control test scores. This data reveals the difficulties patients face as they recover from COVID-19.

By looking at Table 2, we can learn about the specific symptoms that arise in asthma patients after COVID-19. This information can help identify and manage cases of post-COVID asthma. The table suggests that coughing and shortness of breath occur more frequently than wheezing and chest pain after COVID-19. This trend in symptoms can guide healthcare providers in understanding how COVID-19 affects asthma diagnosis and care. It emphasizes the importance of personalized treatment approaches for individuals with new-onset asthma after COVID-19.

Table 3

Table 3 provides detailed information on long COVID-19 asthma symptoms. This includes coughing, wheezing, dyspnea, and chest pain. The data helps us understand asthma post-COVID-19 by highlighting the respiratory symptoms patients may have after recovering from COVID-19.

The table includes factors like age, disease characteristics, hospitalization rates, and pulmonary function measures. This sheds light on how prior COVID-19 infection impacts asthma development and exacerbation.

It also shows insights into the connection between COVID-19 pneumonia, lower respiratory infections, and the likelihood of new-onset asthma or worsened symptoms. By looking at baseline characteristics and outcomes 6-12 months after infection, the table reveals the long-term effects of COVID-19 on lung health and the immune system.

This information is valuable for healthcare professionals who are managing asthma in patients after COVID-19.


The study shows a possible connection between COVID-19 and new asthma symptoms. Patients who have coughing, wheezing, or difficulty breathing after COVID-19 may develop asthma with eosinophilic inflammation. This type of asthma suggests a link between COVID-19 and asthma problems.

Healthcare providers should think about asthma when treating patients with long Covid symptoms. It’s important to understand the risks of COVID-19 and asthma, watch for symptoms, and keep up with vaccinations to lower the chances of infection and long-term issues for asthma patients.

However, the study has limitations. It focused on specific patients and other factors that could affect the results. This makes it hard to apply the findings to a larger group. More research is necessary to confirm the results and study the connection between COVID-19 and asthma further, looking at different demographic and clinical factors in the context of long Covid asthma symptoms.


The study on long COVID outcomes in asthmatic patients received funding from various sources.

The support came from governmental organizations, academic institutions, and research foundations focusing on respiratory diseases.

Financial assistance enabled data collection and analysis of key factors like asthma history, COVID-19 details, and post-COVID symptoms.

The collaborative approach allowed a comprehensive investigation into COVID-19’s impact on asthma patients.

It shed light on the connection between COVID-19 pneumonia and patient characteristics.

These include age, gender, and use of specific treatments.

The funding helped explore how prior COVID-19 infections affect new-onset asthma, long-term symptoms, and overall disease outcomes in this patient group.


Ethical considerations are important when researching sensitive topics like COVID-19 and asthma. Researchers should focus on patient privacy, informed consent, and data protection to maintain ethical standards.

Study participants need to fully understand the risks and benefits of the research. Keeping their personal information confidential is crucial. People should not be exploited or harmed during the study.

Researchers should also think about how their findings affect the community. They should aim to contribute positively to medical knowledge while protecting everyone involved.

Following ethical guidelines allows researchers to study long COVID asthma symptoms with integrity and respect for those affected. This helps enhance the understanding and treatment of these complex respiratory conditions.

Study approval statement

The study looked at long COVID in asthmatic patients. This was done six to twelve months after the COVID-19 infection. A question arises about the approval for this study. Did the appropriate ethics committee or review board approve this research on recovering COVID-19 patients developing new asthma symptoms?

Was there confirmation in the study approval statement that all necessary permissions and consents were obtained? This was essential for studying how COVID-19 affects asthma development in recovering individuals. These considerations are crucial to ethically and scientifically collect data on post-COVID respiratory symptoms, coughing, wheezing, chest pain, and other asthma-related issues.

By ensuring proper approval, the rights and well-being of patients with pre-existing or new-onset asthma post-COVID are protected. Clear study approval also improves the reliability of findings on asthma control, lung function, and potential barriers to hospitalization and ICU admissions.

Ethical oversight is vital in studies involving COVID-19, asthma, and post-COVID syndrome. It helps ensure valuable insights into disease management and patient outcomes.

The consent to publish statement regarding asthma and long COVID has many important points to think about.

COVID-19 patients who develop asthma afterwards might have symptoms like coughing, wheezing, difficulty breathing, and chest pain. These symptoms could show eosinophilic inflammation, linking COVID-19 to asthma.

Knowing how the disease progresses is crucial for treating asthma effectively after recovering from COVID-19. This treatment may include using inhaled corticosteroids and adjusting immunoglobulin E levels to manage symptoms and airflow post-recovery.

It’s important to monitor asthma control, risk of exacerbations, and lung function after COVID-19. This is especially true for people with T2 asthma or those who develop asthma later in life.

Considering individual characteristics, risk factors, and severity of the disease can help in decisions about hospital stays, ICU visits, and long-term care for those who develop asthma following a previous COVID-19 infection. This emphasizes the importance of continuous assessment and care.

CRediT authorship contribution statement

The research project looked at COVID-19 and asthma. Multiple authors were involved. Each author had specific contributions. They studied patients who developed asthma after COVID-19. They looked at symptoms like coughing, wheezing, and difficulty breathing.

The authors analyzed asthma characteristics. This included asthma control, lung function, and the use of certain medications. They also considered factors such as age, smoking, and prior COVID-19 infection when looking at asthma after COVID-19.

The authors studied respiratory infections after COVID-19. They found a link between pneumonia and male patients, smokers, and specific treatments. They also monitored asthmatic patients for long-term effects of COVID-19.

The study showed a connection between COVID-19 and new-onset asthma in adults. It provided insights into diagnosing asthma, the chances of being hospitalized, and treatments for a type of asthma that affects outcomes.

Declaration of competing interest

Patients with COVID-19 who develop new-onset asthma may experience symptoms like coughing, wheezing, and difficulty breathing. Some may need hospitalization due to severe respiratory issues, which could lead to long-term COVID-19 complications.

Factors such as age, disease severity, and past COVID-19 infection play a role in the likelihood of adults developing new-onset asthma after recovering from COVID-19. Understanding how COVID-19 impacts asthma based on initial characteristics can help assess the risk of disease progression and plan optimal management approaches.

Respiratory infections like pneumonia can worsen asthma symptoms, requiring careful monitoring and treatment. Healthcare providers should consider the acute phase of COVID-19 when treating patients with asthma, ensuring proper therapy to manage asthma and prevent complications.

It is essential to monitor respiratory function, airflow, and immune responses after COVID-19 infection to prevent long-term respiratory and overall health issues.


Acknowledgements in asthma long covid involve recognizing:

  • Healthcare professionals
  • Researchers
  • Patients

These individuals contribute valuable insights into the connection between COVID-19 and new-onset asthma.

Efforts like Olusegun Oseni’s studies on post-COVID-19 patients, identifying symptoms such as coughing, wheezing, and dyspnea, and exploring eosinophilic inflammation’s impact on asthma expand our understanding of this disease interaction.

Organizations play a crucial role in:

  • Facilitating data collection
  • Providing insights into T2 asthma phenotypes
  • Highlighting the importance of symptom monitoring during the acute disease phase

Collaboration among healthcare providers, researchers, and patients is essential in recognizing risks from prior COVID-19 infection, potential long COVID-19 development, and impacts on asthma outcomes. This collaboration advances patient care and disease management in the face of evolving challenges.

Contributor Information

A new study suggests a rare link between recent COVID-19 infection and the development of new-onset asthma. This connection is particularly related to eosinophilic inflammation.

Patients who showed respiratory symptoms after COVID-19, with some being diagnosed with new asthma, experienced symptoms like coughing, wheezing, and difficulty breathing. They responded well to asthma treatment.

Testing revealed eosinophilic inflammation, indicating a T2-high nonallergic asthma type. It’s crucial to consider asthma as a potential cause of respiratory symptoms after COVID-19.

The blog also mentions rare cases of people developing asthma or having asthma attacks after getting the COVID-19 vaccine. Although adverse events are uncommon, the benefits of vaccination usually outweigh the risks.

Understanding the risks regarding COVID-19 and asthma, monitoring symptoms closely, and staying informed about vaccination can help reduce the risk of infection and any potential long-term effects.


What are the common symptoms of long Covid asthma?

Common symptoms of long Covid asthma include persistent coughing, shortness of breath, chest tightness, and difficulty breathing during physical activity. It is important to seek medical advice if you experience these symptoms for proper evaluation and treatment.

How long do long Covid asthma symptoms typically last?

Long Covid asthma symptoms can last for weeks to months, with some cases lasting up to a year or longer. It is important to work with a healthcare provider to manage symptoms and improve overall lung function.

Can long Covid asthma symptoms worsen over time?

Yes, long Covid asthma symptoms can worsen over time if left untreated. Monitoring symptoms closely, following an asthma action plan, avoiding triggers, and seeking medical intervention can help prevent symptom progression.

Are there any specific triggers that can worsen long Covid asthma symptoms?

Common triggers that can worsen long Covid asthma symptoms include air pollution, allergens (such as pollen or dust mites), respiratory infections, and stress. Avoiding these triggers and staying on top of asthma management can help mitigate symptoms.

What are the treatment options for managing long Covid asthma symptoms?

The treatment options for managing long Covid asthma symptoms may include inhalers, medications such as corticosteroids, regular monitoring with a healthcare provider, and pulmonary rehabilitation programs.

Related PubMed Articles: